MedChem Module 4 Lecture 4.4

Factors Affecting Drug Biotransformation

Definition of Drug Biotransformation: Refers to the chemical modification made by an organism on a substance.
Importance: Understanding biotransformation is critical as it influences drug efficacy and safety.

Molecular Structure: The chemical structure of a drug impacts its metabolism.
Enzyme Presence: Number of enzymes available and their affinity to the drug are crucial.

Drugs and Food as Inducers:
- Certain drugs can upregulate specific cytochrome P450 (CYP) enzymes, enhancing drug metabolism.
- Foods can contain natural compounds that induce drug metabolizing enzymes.
- Induction effects vary based on the dose or exposure level and the potency of the inducer.

Interaction Mechanism:
- Drug A can either induce or inhibit the enzyme responsible for the metabolism of Drug B.
- Combining Drug A and Drug B may lead to increased or decreased effects of Drug B, demonstrating drug-drug interactions.
Transcription Factor Regulation:
- Drug A may also regulate the expression of an enzyme through its effect on transcription factors, leading to altered metabolism of Drug B.
Clinical Example:
- Rifampin and Birth Control Pills:
  - Rifampin (an antibiotic) induces CYP3A4, leading to faster metabolism of acinyl estradiol in birth control pills, potentially causing unintended pregnancies.
- Charcoal-Broiled Food and Theophylline:
  - Charcoal-broiled foods can induce CYP1A2, increasing metabolism of theophylline, which is used for asthma, leading to inadequate dosing.
- Herbal Remedies: Particularly those inducing CYP3A4 can lead to decreased efficacy of many drugs being metabolized by that enzyme.

Induction of enzymes can lead to:
- Accelerated biotransformation of drug substrates catalyzed by the induced enzymes.
- Potential need for dose adjustments when combining inducer drugs with others.

Inhibitors can lead to slow metabolism of other drugs taken concurrently, increasing toxicity risk.

Strong Inducers:
- Rifampin (CYP3A4), barbiturates (UGT), St. John's Wort (CYP3A4).
Weak Inducers:
- Bioflavonoids (CYP and GST), garlic and onion (CYP and GST).
Factors Affecting Enzyme Activity:
- Diet (e.g., smoked foods), alcohol consumption can affect specific CYP activities (like CYP2E1).

Cytokines: Secreted during inflammation can suppress enzyme activity, affecting drug metabolism.
Liver Diseases: Conditions like cirrhosis can lead to reduced drug metabolizing enzyme activity, leading to toxicity at standard dosages.

Nutritional status affects the availability of cofactors and cosubstrates, impacting enzyme activity:
- Healthy Nutrition: Higher concentrations of cofactors such as UDP glucuronic acid, glutathione (GSH), NADPH contribute to efficient metabolism.
- Poor Nutrition: Low concentrations of glutathione and free amino acids might lead to decreased metabolic capacity.

Direct drug-food interactions can enhance or inhibit enzymatic activity without affecting enzyme amounts directly.
Grapefruit Juice: Contains compounds that inhibit CYP3A4 and P-glycoprotein, affecting the bioavailability of various drugs.
Bioflavonoids in Foods: Compounds in foods that can inhibit CYP enzymes and affect drug metabolism.

Biotransformation rates are influenced by factors such as drug structure, genetic variability, interactions between drugs and food, and nutritional status.
Understanding these diverse factors is vital for appropriate drug dosage and therapeutic efficacy.
Close observation and adjustment may be necessary in clinical settings to account for these various influences to prevent toxicity or therapeutic failure.